Europe Dietary Supplements Market Size, Share & Trends Analysis Report By Ingredient (Vitamins, Minerals), By Type (OTC, Prescribed), By End-user, By Form, By Application, By Distribution Channel And Segment Forecasts, 2023 - 2030

Europe Dietary Supplements Growth & Trends

The Europe dietary supplements market is anticipated to reach USD 65.44 billion by 2030, growing at a CAGR of 7.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market for dietary supplements in Europe is being driven by several factors, including the growing interest in preventive healthcare among consumers. As people become more aware of the importance of maintaining good health and preventing chronic diseases, they are turning to dietary supplements as a way to support their overall health and well-being. Additionally, the aging population in Europe is driving demand for supplements that address age-related health concerns such as joint health, cognitive function, and eye health.

In addition, the increasing popularity of natural and organic products. Consumers are becoming more concerned about the potential side effects of synthetic ingredients and are seeking out supplements that contain natural ingredients. This trend is particularly strong among younger consumers, who are more likely to prioritize environmentally and socially responsible products.

Furthermore, the rise of e-commerce and the increasing availability of supplements online have made it easier for consumers to access a wider range of products, which has further fueled the growth of the market. In addition, the COVID-19 pandemic has led to increased interest in supplements that support immune health, which has further boosted sales of these products.

The key players in Europe are heavily investing in research and development, product launches, focusing on mergers and acquisitions to enhance their product offerings and create innovative formulations with superior properties to meet the growing demand. For instance, in February 2023, Comple.med launched Lactoflor Immuno 200 in Europe, which has 50mg of IMMUSE, a postbiotic that activates pDC cells, 200mg of Lactoferin, and 25mcg of Vitamin D3. IMMUSE is backed by 29 published studies, including 14 human clinical trials, and is marketed by Kyowa Hakko.

Europe Dietary Supplements Market Report Highlights

• Vitamins dominated the ingredients category with the highest revenue share of 29.91% in 2022, owing to the number of newly launched multivitamin supplements and the rising awareness of lifestyle-related illnesses.
• The tablets accounted for a revenue share of 33.25% in 2022. The tablets are convenient and easy to use, making them a popular choice for consumers. They are also easy to manufacture and store, which makes them a cost-effective option for manufacturers.
• The market for prenatal health is expected to grow at a CAGR of 10.3% over the forecast period. Pregnant women are increasingly aware of the importance of proper nutrition during pregnancy for the health and development of their babies. This has led to a demand for dietary supplements that can help ensure an adequate intake of key nutrients such as folic acid, iron, and calcium.
• The market for infants is expected to grow at a CAGR of 11.7% during the projected period owing to the introduction of innovative and convenient supplement formats such as gummies, drops, and powders, coupled with aggressive marketing and promotional strategies by manufacturers, have further fueled the demand.
• The OTC (Over the Counter) market dominated the market with a share of 73.44% in 2022. The consumer trend of self-directed health care is likely to drive the demand for OTC supplements.
• The offline distribution channel dominated the market with a share of 82.38% in 2022. The prevalence of supermarkets/hypermarkets in Europe is higher, and as a result, these offline channels make a significant contribution to the sales of dietary supplements.
• Spain is anticipated to grow at a CAGR of 7.7% over the forecast period owing to the increasing health consciousness among consumers and the rising incidence of chronic diseases.
• Some of the key players in the market include Nestle, Abbott, Bayer AG, Glanbia plc, Pfizer Inc., Archer Daniels Midland, GlaxoSmithKline plc., NU SKIN, Herbalife Nutrition, Nature's Sunshine Products Inc., Bionova, Arkopharma.

Please note The report will be delivered in 4-8 business days upon order notification.